Trials
Search / Trial NCT05643352

Barbed Reposition Pharyngoplasty in Patients Complaining of Unilevel Palatal Snoring

Launched by AZ DELTA · Dec 7, 2022

Trial Information

Current as of February 05, 2025

Unknown status

Keywords

Pharyngoplasty Barbed Reposition Pharyngoplasty Snoring Surgery

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • single-level retro-palatal collapse observed during drug-induced sleep endoscopy (DISE)
  • Exclusion Criteria:
  • OSAS defined as having an obstructive AHI (OAHI) ≥ 30
  • Obese patients with a body mass index (BMI) ≥ 30 kg/m².
  • Patients with multilevel airway collapse observed during DISE
  • Patients younger than 18 years old.

About Az Delta

Az Delta is a leading clinical trial sponsor dedicated to advancing medical research and innovative therapies. With a focus on enhancing patient outcomes, the organization specializes in the design and management of clinical studies across various therapeutic areas. Az Delta is committed to upholding the highest standards of ethical practices and regulatory compliance, ensuring the integrity and reliability of trial results. Collaborating with healthcare professionals, research institutions, and industry partners, Az Delta strives to accelerate the development of groundbreaking treatments that address unmet medical needs, ultimately contributing to the improvement of global health.

Locations

Roeselare, , Belgium

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0

Similar Trials